Adalta Ltd has released a press release.
Tim Oldham Appointed as Chief Executive Officer
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from AdAlta
- Receipt of R&D Tax Incentive
- AdAlta secures licensing deal with GE Healthcare
- Executive team changes
- GLP toxicology study commences
- Entitlement Offer Results and Shortfall Notification
Later from AdAlta
- GLP Toxicology study results
- AdAlta awarded Biomedical Translation Bridge Funding
- AD-214 Phase I strategy and timing update
- AdAlta Granted US Patent for AD-214
- Appendix 4C - quarterly
Follow AdAlta into a list and get an email when it puts out news.
Follow AdAlta